Michael DeRosa
Michael DeRosa publishes mostly in Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, Health Systems, Economic Evaluations, Quality of Life and Lung Cancer Treatments and Mutations.
- World rank
- #1,664,561 of 7,710,434 ranked researchers
- Rank in United States
- #515,848 of 1,627,098
- Works
- 52
- Citations
- 1.5k
- Citations per work
- 28.5
What does Michael DeRosa research?
Michael DeRosa's work is mostly in Medicine (41%), Economics, Econometrics and Finance (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2241.9%
- Health Sciences2141.3%
- Medicine2141.3%
- Social Sciences916.8%
- 1Economics and Econometrics17% of their works
- 2Oncology15% of their works
- 3Pulmonary and Respiratory Medicine13% of their works
- 4Otorhinolaryngology5% of their works
- 5Surgery4% of their works
- 6Epidemiology4% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Head and Neck Cancer Studies
- Psoriasis: Treatment and Pathogenesis
- Multiple and Secondary Primary Cancers
- Lung Cancer Diagnosis and Treatment
Which keywords describe Michael DeRosa's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Immune Checkpoint Blockade, PD-1 and PD-L1, Quality of Life, Chemotherapy, Cost of Care, EGFR Mutations and Financial Toxicity.
- TH17 Cells
- Multiple Primary Cancers
- IL-17
- Oropharyngeal Cancer
- Targeted Therapy
- Financial Toxicity
- Cost of Care
- Quality of Life
- Immune Checkpoint Blockade
- Cost-effectiveness Analysis
- PD-1 and PD-L1
- Chemotherapy
- EGFR Mutations
- Radiotherapy
- Human Papillomavirus
- CT Screening
- Lung Cancer
- Second Primary Neoplasms
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cost-effectiveness Analysis131 topic
- Immune Checkpoint Blockade131 topic
- PD-1 and PD-L1131 topic
- Quality of Life131 topic
- Chemotherapy102 topics
- Cost of Care101 topic
- EGFR Mutations101 topic
- Financial Toxicity101 topic
- Radiotherapy102 topics
- Targeted Therapy101 topic
- Human Papillomavirus61 topic
- Oropharyngeal Cancer61 topic
- CT Screening41 topic
- IL-1741 topic
- Lung Cancer41 topic
- Multiple Primary Cancers41 topic
- Second Primary Neoplasms41 topic
- TH17 Cells41 topic
Where does Michael DeRosa work?
Michael DeRosa's main affiliation in the publication record is Adelphi Laboratory Center, United States.
How many publications and citations does Michael DeRosa have?
OpenAlex counts 52 works and 1,480 citations for Michael DeRosa, an h-index of 12, ranking #1,664,561 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Michael DeRosa
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael DeRosa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.